Aurinia Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Chin Kyu Huh(5.2%),ILJIN SNT Co., Ltd.(4.4%), etc.
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Greenleaf Peter
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Donley Matthew Maxwell
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Miller Joseph M
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Habig Scott Michael
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Robertson Stephen P.
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Knappertz Volker
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Knappertz Volker
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Habig Scott Michael
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Donley Matthew Maxwell
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Robertson Stephen P.
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Miller Joseph M
Aurinia Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Robertson Stephen P.
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Greenleaf Peter
Aurinia Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Miller Joseph M
Aurinia Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Greenleaf Peter
Aurinia Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(6.64%),Steven Boyd(6.64%)
Aurinia Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(6.2%)
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Foster Robert T
Aurinia Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Foster Robert T
No Data